(Q50949572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Reduction of the washout time between natalizumab and fingolimod (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jerome de Seze

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Nicolas Collongues

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jean-Baptiste Chanson

8

object named as

Jean-Baptiste Chanson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

2

Jean-Claude Ongagna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

7

Aurélien Benoilid

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Christophe Zaenker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sylvie Courtois

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Marie Fleury

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Alsacep Network

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

30 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.

2 March 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458513490551

Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458513490551

Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458513490551

21 January 2018

Identifiers

DOI

10.1177/1352458513490551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23722322%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference